Treatment of oral cancer cell lines with the CH1 inhibitor (CH1iB), interrupts E6 HPV 16 protein and p300 binding and consequently enhances p53 acetylation that further stimulates its transcription [40]. Here, TP53 is linked to lip and oral cavity carcinoma.